Europe Clinical Laboratory Tests Market Size & Outlook
The clinical laboratory tests market in Europe is expected to reach a projected revenue of US$ 65,211.9 million by 2033. A compound annual growth rate of 10.2% is expected of Europe clinical laboratory tests market from 2026 to 2033.
In terms of revenue, Europe region accounted for 21.7% of the global clinical laboratory tests market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 71,093.1 million by 2033.
Europe held the second-largest share of the clinical laboratory tests market due to presence of major research institutes and market players operating in the region. Moreover, favorable initiatives undertaken by the government and other nonprofit organizations to provide funds for R&D activities and create awareness about the benefits of early disease diagnosis are expected to boost market growth.
Chronic diseases, such as cardiovascular, cancer, respiratory disease, diabetes, and stroke, account for 77% of the total disease burden and 86% of all regional deaths. For instance, in Europe, around 3.9 million people die due to cardiovascular diseases every year, and around 29 million people suffer from a chronic liver condition, which is also a major cause of death in Europe.
Several initiatives undertaken by government and private organizations to fund R&D about clinical laboratory tests & services and create awareness about the benefits of early diagnosis are expected to boost the Europe clinical laboratory tests market growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Clinical Laboratory Tests Market Outlook will help companies and investors design strategic landscapes.
Hba1C Tests was the largest segment with a revenue share of 13.77% in 2025.
Horizon Databook has segmented the Europe clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, lipid panel tests, renal panel tests, liver panel tests covering the revenue growth of each sub-segment from 2021 to 2033.
Europe held the second-largest share of the clinical laboratory tests market due to presence of major research institutes and market players operating in the region. Moreover, favorable initiatives undertaken by the government and other nonprofit organizations to provide funds for R&D activities and create awareness about the benefits of early disease diagnosis are expected to boost market growth.
Chronic diseases, such as cardiovascular, cancer, respiratory disease, diabetes, and stroke, account for 77% of the total disease burden and 86% of all regional deaths. For instance, in Europe, around 3.9 million people die due to cardiovascular diseases every year, and around 29 million people suffer from a chronic liver condition, which is also a major cause of death in Europe.
Several initiatives undertaken by government and private organizations to fund R&D about clinical laboratory tests & services and create awareness about the benefits of early diagnosis are expected to boost the Europe clinical laboratory tests market growth.
Europe Clinical Laboratory Tests Market Type Outlook (Revenue, USD Million , 2021-2033)
Complete blood count
HGB/HCT tests
Basic metabolic panel
BUN creatinine tests
Electrolytes testing
HbA1c tests
Comprehensive metabolic panel tests
Liver panel tests
Renal panel tests
Lipid panel tests
Others
Europe Clinical Laboratory Tests Market End-use Outlook (Revenue, USD Million , 2021-2033)
Primary Clinics
Central Laboratories
Reasons to subscribe to Clinical Laboratory Tests Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Clinical Laboratory Tests Market Outlook databook
Our clientele includes a mix of Clinical Laboratory Tests Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Clinical Laboratory Tests Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Clinical Laboratory Tests Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Clinical Laboratory Tests Market, 2021-2033 (US$M)